These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases. Primiano T; Egner PA; Sutter TR; Kelloff GJ; Roebuck BD; Kensler TW Cancer Res; 1995 Oct; 55(19):4319-24. PubMed ID: 7671242 [TBL] [Abstract][Full Text] [Related]
3. Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry. Roebuck BD; Liu YL; Rogers AE; Groopman JD; Kensler TW Cancer Res; 1991 Oct; 51(20):5501-6. PubMed ID: 1680553 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Kensler TW; Egner PA; Dolan PM; Groopman JD; Roebuck BD Cancer Res; 1987 Aug; 47(16):4271-7. PubMed ID: 2886217 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz. Roebuck BD; Curphey TJ; Li Y; Baumgartner KJ; Bodreddigari S; Yan J; Gange SJ; Kensler TW; Sutter TR Carcinogenesis; 2003 Dec; 24(12):1919-28. PubMed ID: 14555609 [TBL] [Abstract][Full Text] [Related]
6. Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer. Kensler TW; Gange SJ; Egner PA; Dolan PM; Muñoz A; Groopman JD; Rogers AE; Roebuck BD Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):603-10. PubMed ID: 9264273 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver. Davidson NE; Egner PA; Kensler TW Cancer Res; 1990 Apr; 50(8):2251-5. PubMed ID: 2317812 [TBL] [Abstract][Full Text] [Related]
9. Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases. Kensler TW; Egner PA; Davidson NE; Roebuck BD; Pikul A; Groopman JD Cancer Res; 1986 Aug; 46(8):3924-31. PubMed ID: 2873884 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the post-initiation effects of oltipraz on aflatoxin B1-induced preneoplastic foci in a rat model of hepatic tumorigenesis. Maxuitenko YY; MacMillan DL; Kensler TW; Roebuck BD Carcinogenesis; 1993 Nov; 14(11):2423-5. PubMed ID: 8242875 [TBL] [Abstract][Full Text] [Related]
11. Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole. Yates MS; Kwak MK; Egner PA; Groopman JD; Bodreddigari S; Sutter TR; Baumgartner KJ; Roebuck BD; Liby KT; Yore MM; Honda T; Gribble GW; Sporn MB; Kensler TW Cancer Res; 2006 Feb; 66(4):2488-94. PubMed ID: 16489057 [TBL] [Abstract][Full Text] [Related]
12. Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers. Kensler TW; He X; Otieno M; Egner PA; Jacobson LP; Chen B; Wang JS; Zhu YR; Zhang BC; Wang JB; Wu Y; Zhang QN; Qian GS; Kuang SY; Fang X; Li YF; Yu LY; Prochaska HJ; Davidson NE; Gordon GB; Gorman MB; Zarba A; Enger C; Muñoz A; Helzlsouer KJ Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):127-34. PubMed ID: 9488587 [TBL] [Abstract][Full Text] [Related]
13. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention. Buetler TM; Bammler TK; Hayes JD; Eaton DL Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305 [TBL] [Abstract][Full Text] [Related]
14. Molecular dosimetry of urinary aflatoxin-N7-guanine and serum aflatoxin-albumin adducts predicts chemoprotection by 1,2-dithiole-3-thione in rats. Groopman JD; DeMatos P; Egner PA; Love-Hunt A; Kensler TW Carcinogenesis; 1992 Jan; 13(1):101-6. PubMed ID: 1733561 [TBL] [Abstract][Full Text] [Related]
15. Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz. Egner PA; Gange SJ; Dolan PM; Groopman JD; Muñoz A; Kensler TW Carcinogenesis; 1995 Aug; 16(8):1769-73. PubMed ID: 7634402 [TBL] [Abstract][Full Text] [Related]
16. Effect of diet on aflatoxin B1-DNA binding and aflatoxin B1-induced glutathione S-transferase placental form positive hepatic foci in the rat. Kimura M; Lehmann K; Gopalan-Kriczky P; Lotlikar PD Exp Mol Med; 2004 Aug; 36(4):351-7. PubMed ID: 15365254 [TBL] [Abstract][Full Text] [Related]
17. Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats. Rao CV; Rivenson A; Katiwalla M; Kelloff GJ; Reddy BS Cancer Res; 1993 Jun; 53(11):2502-6. PubMed ID: 8495412 [TBL] [Abstract][Full Text] [Related]
18. Indole-3-carbinol induces a rat liver glutathione transferase subunit (Yc2) with high activity toward aflatoxin B1 exo-epoxide. Association with reduced levels of hepatic aflatoxin-DNA adducts in vivo. Stresser DM; Williams DE; McLellan LI; Harris TM; Bailey GS Drug Metab Dispos; 1994; 22(3):392-9. PubMed ID: 8070315 [TBL] [Abstract][Full Text] [Related]
19. Temporal patterns of DNA adduct formation and glutathione S-transferase activity in the testes of rats fed aflatoxin B1: a comparison with patterns in the liver. Sotomayor RE; Sahu S; Washington M; Hinton DM; Chou M Environ Mol Mutagen; 1999; 33(4):293-302. PubMed ID: 10398377 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of aflatoxin Ml excretion in rat urine during dietary intervention with oltipraz. Scholl P; Musser SM; Kensler TW; Groopman JD Carcinogenesis; 1996 Jun; 17(6):1385-8. PubMed ID: 8681461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]